Venetoclax-based combinations for acute myeloid leukemia: optimizing their use in Latin-America

Venetoclax-based combinations for acute myeloid leukemia: optimizing their use in Latin-America

Objectives: Venetoclax combinations are a new standard for patients with acute myeloid leukemia (AML). We aimed to evaluate the safety and efficacy of these combinations in a period of accelerated approval in Latin-America. Methods: This observational study evaluated adults with acute myeloid leukem...

Full description

Bibliographic Details
Main Authors: Andrés Gómez-De León, Roberta Demichelis-Gómez, Alfredo Pinedo-Rodríguez, Daniel Enriquez-Vera, Juan Antonio Flores-Jiménez, Adrián Alejandro Ceballos-López, Margarita Rodríguez-Mejorada, Miguel Angel Herrera Riojas, Roberto Ovilla-Martínez, Pamela Báez-Islas, Xóchitl Cota-Rangel, Yvette Neme-Yunes, Sergio Inclán-Alarcón, Nelson J. López-Flores, Perla R. Colunga-Pedraza, Anna C. Rodríguez-Zúñiga, David Gómez-Almaguer
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Hematology
Subjects:
acute myeloid leukemia
venetoclax
azacytidine
cytarabine
bcl-2 inhibitor
Online Access:http://dx.doi.org/10.1080/16078454.2021.2024940

Internet

http://dx.doi.org/10.1080/16078454.2021.2024940

Similar Items